DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 201280
The generic ingredient in TRADJENTA is linagliptin. There are eighteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the linagliptin profile page.
Summary for 201280
Tradename: | TRADJENTA |
Applicant: | Boehringer Ingelheim |
Ingredient: | linagliptin |
Patents: | 12 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 201280
Mechanism of Action | Dipeptidyl Peptidase 4 Inhibitors |
Medical Subject Heading (MeSH) Categories for 201280
Suppliers and Packaging for NDA: 201280
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRADJENTA | linagliptin | TABLET;ORAL | 201280 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0140 | N | 0597-0140-90 |
TRADJENTA | linagliptin | TABLET;ORAL | 201280 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0140 | N | 0597-0140-30 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | May 2, 2011 | TE: | RLD: | Yes | |||||
Patent: | ➤ Sign Up | Patent Expiration: | Feb 2, 2019 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING LINAGLIPTIN IN COMBINATION WITH INSULIN (WITH OR WITHOUT METFORMIN AND/OR PIOGLITAZONE) | ||||||||
Patent: | ➤ Sign Up | Patent Expiration: | Feb 2, 2019 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATMENT OF TYPE 2 DIABETES MELLITUS | ||||||||
Patent: | ➤ Sign Up | Patent Expiration: | Feb 2, 2019 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING LINAGLIPTIN IN COMBINATION WITH INSULIN (WITH OR WITHOUT METFORMIN AND/OR PIOGLITAZONE) |
Expired US Patents for NDA 201280
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Boehringer Ingelheim | TRADJENTA | linagliptin | TABLET;ORAL | 201280-001 | May 2, 2011 | ➤ Sign Up | ➤ Sign Up |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Complete Access Available with Subscription